Cargando…

181 Identifying Racial Disparities in the Pain Management of Hidradenitis Suppurativa

OBJECTIVES/GOALS: The purpose of this study is to evaluate average pain scores in patients with Hidradenitis Suppurativa (HS) and determine if racial disparities influence HS-related pain management. METHODS/STUDY POPULATION: We surveyed 3,140 adult patients about demographics, HS, pain levels, medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Weir, Sydney, MacLennan, Paul A., Kole, Lauren C.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209087/
http://dx.doi.org/10.1017/cts.2022.87
_version_ 1784729861997199360
author Weir, Sydney
MacLennan, Paul A.
Kole, Lauren C.S.
author_facet Weir, Sydney
MacLennan, Paul A.
Kole, Lauren C.S.
author_sort Weir, Sydney
collection PubMed
description OBJECTIVES/GOALS: The purpose of this study is to evaluate average pain scores in patients with Hidradenitis Suppurativa (HS) and determine if racial disparities influence HS-related pain management. METHODS/STUDY POPULATION: We surveyed 3,140 adult patients about demographics, HS, pain levels, medical history, and health-related quality of life. Among respondents (N=162), pain scores (0-10) were grouped as high (8+, N=54) and low (<7, N=108). We used logistic regression to calculate adjusted odds ratios (aOR) and 95% confidence intervals (95% CI). RESULTS/ANTICIPATED RESULTS: Respondents were female (88.9%), Black race (59.4%), with a median age of 36 (IQR 25-42) and a mean pain score of 7 (IQR 5-8). Half (48.2%) of respondents disagreed or strongly disagreed with, “I am satisfied with how my pain related to HS is being managed by my doctors.” Independent risk factors for high pain included Black race (aOR=7.95, 95% CI 3.11-20.26), history of prescribed pain medications (aOR=2.37, 95% CI 1.06-5.30), and former/current tobacco use (aOR=4.12, 95% CI 1.76-9.64). DISCUSSION/SIGNIFICANCE: The preliminary data support the hypothesis that race influences HS-related pain. In addition, less education, a history of prescription pain medication use, and tobacco use are all independent risk factors contributing to higher pain scores in patients with HS. Further analysis will be conducted to evaluate racial influences on pain management.
format Online
Article
Text
id pubmed-9209087
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-92090872022-07-01 181 Identifying Racial Disparities in the Pain Management of Hidradenitis Suppurativa Weir, Sydney MacLennan, Paul A. Kole, Lauren C.S. J Clin Transl Sci Diversity, Equity, and Inclusion OBJECTIVES/GOALS: The purpose of this study is to evaluate average pain scores in patients with Hidradenitis Suppurativa (HS) and determine if racial disparities influence HS-related pain management. METHODS/STUDY POPULATION: We surveyed 3,140 adult patients about demographics, HS, pain levels, medical history, and health-related quality of life. Among respondents (N=162), pain scores (0-10) were grouped as high (8+, N=54) and low (<7, N=108). We used logistic regression to calculate adjusted odds ratios (aOR) and 95% confidence intervals (95% CI). RESULTS/ANTICIPATED RESULTS: Respondents were female (88.9%), Black race (59.4%), with a median age of 36 (IQR 25-42) and a mean pain score of 7 (IQR 5-8). Half (48.2%) of respondents disagreed or strongly disagreed with, “I am satisfied with how my pain related to HS is being managed by my doctors.” Independent risk factors for high pain included Black race (aOR=7.95, 95% CI 3.11-20.26), history of prescribed pain medications (aOR=2.37, 95% CI 1.06-5.30), and former/current tobacco use (aOR=4.12, 95% CI 1.76-9.64). DISCUSSION/SIGNIFICANCE: The preliminary data support the hypothesis that race influences HS-related pain. In addition, less education, a history of prescription pain medication use, and tobacco use are all independent risk factors contributing to higher pain scores in patients with HS. Further analysis will be conducted to evaluate racial influences on pain management. Cambridge University Press 2022-04-19 /pmc/articles/PMC9209087/ http://dx.doi.org/10.1017/cts.2022.87 Text en © The Association for Clinical and Translational Science 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Diversity, Equity, and Inclusion
Weir, Sydney
MacLennan, Paul A.
Kole, Lauren C.S.
181 Identifying Racial Disparities in the Pain Management of Hidradenitis Suppurativa
title 181 Identifying Racial Disparities in the Pain Management of Hidradenitis Suppurativa
title_full 181 Identifying Racial Disparities in the Pain Management of Hidradenitis Suppurativa
title_fullStr 181 Identifying Racial Disparities in the Pain Management of Hidradenitis Suppurativa
title_full_unstemmed 181 Identifying Racial Disparities in the Pain Management of Hidradenitis Suppurativa
title_short 181 Identifying Racial Disparities in the Pain Management of Hidradenitis Suppurativa
title_sort 181 identifying racial disparities in the pain management of hidradenitis suppurativa
topic Diversity, Equity, and Inclusion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209087/
http://dx.doi.org/10.1017/cts.2022.87
work_keys_str_mv AT weirsydney 181identifyingracialdisparitiesinthepainmanagementofhidradenitissuppurativa
AT maclennanpaula 181identifyingracialdisparitiesinthepainmanagementofhidradenitissuppurativa
AT kolelaurencs 181identifyingracialdisparitiesinthepainmanagementofhidradenitissuppurativa